ClinVar Miner

Submissions for variant NC_000011.10:g.(?_108227615)_(108229333_?)del

Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 1
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Labcorp Genetics (formerly Invitae), Labcorp RCV000803280 SCV000943143 pathogenic Ataxia-telangiectasia syndrome 2019-02-04 criteria provided, single submitter clinical testing This variant is a gross deletion of the genomic region encompassing exons 2-4 of the ATM gene, which includes the initiator codon. The 5' end of this event is unknown as it extends beyond the assayed region for this gene and therefore may encompass additional genes. The 3' boundary is likely confined to intron 4 of the ATM gene. This is expected to result in an absent or disrupted protein product. Similar deletion of exons 2-4 has not been reported in the literature in individuals with ATM-related disease. However, a deletion of exons 2-3 (also known as exons 1-2 in the literature), which removes the initiator codon in exon 2, has been observed in individuals affected with breast cancer (PMID: 28486781). Loss-of-function variants in ATM are known to be pathogenic (PMID: 23807571, 25614872). For these reasons, this variant has been classified as Pathogenic.

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.